Patent directory · USPTO A61K / A61P
Patents matching “The United States of America, as represented by the Secretary, Department of Health”
1,166 pharma patents match "The United States of America, as represented by the Secretary, Department of Health" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,166 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8828936
Therapeutic use of SCGB3A2
granted -
US 8828380
Method for the treatment of pulmonary disease and method of producing proteins of use therein
granted -
US 8822540
Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation
granted -
US 8821866
Methods of treating and preventing colitis involving IL-13 and NK-T cells
granted -
US 8822196
Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
granted -
US 8822434
Compositions and methods to treat cardiac diseases
granted -
US 8816059
Method for predicting and detecting tumor metastasis
granted -
US 8815229
Granulysin in immunotherapy
granted -
US 8808684
Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction
granted -
US 8795674
Methods and compositions for modulating immune tolerance
granted -
US 8796302
Methods related to the treatment of neurodegenerative and inflammatory conditions
granted -
US 8796291
A3 adenosine receptor antagonists and partial agonists
granted -
US 8795964
GRM3 mutations and use thereof for the diagnosis and treatment of melanoma
granted -
US 8795680
Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-D-manno-octulsonic acid
granted -
US 8790635
Live, oral vaccine for protection against Shigella dysenteriae serotype 1
granted -
US 8791074
Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
granted -
US 8790869
Renal cell carcinoma biomarkers
granted -
US 8785601
T cell receptors and related materials and methods of use
granted -
US 8785414
Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of Sjögren's syndrome
granted -
US 8778354
Compositions and methods for modulating RSV infection and immunity
granted -
US 8779095
LAT adapter molecule for enhanced T-cell signaling and method of use
granted -
US 8772256
Codon modified immunogenic compositions and methods of use
granted -
US 8759014
Methods of obtaining antigen-specific T cell populations
granted -
US 8754030
Defensin-antigen fusion proteins
granted